Trial on Three Treatments for Scoliosis
Launched by KAROLINSKA INSTITUTET · Jan 3, 2013
Trial Information
Current as of May 01, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating three different treatments for idiopathic scoliosis, a condition where the spine curves abnormally and typically affects children and teenagers. The study aims to compare the effectiveness of wearing a brace at night, doing specific exercises for scoliosis, and following a prescribed physical activity plan. The goal is to see which method works best in helping adolescents with this condition.
To be eligible for this trial, participants need to be diagnosed with idiopathic scoliosis and still have some growth remaining, which is usually indicated by being less than one year past their first menstrual period. They should also have a spine curve measuring between 25 and 40 degrees and the curve should be located in a specific area of the spine. Unfortunately, those who have scoliosis due to other medical issues or who have already received treatment like braces or surgery for scoliosis cannot join. While the trial is currently active, it is not taking any new participants at this time. If eligible, participants can expect to engage in one of the three treatment methods and contribute to important research that may improve care for others with scoliosis in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of idiopathic scoliosis
- • Skeletally immature with estimated remaining growth for at least one year.
- • Not more than one year after menarche
- • Primary Cobb angle between 25 and 40 degrees.
- • Curve apex T7 or caudal
- Exclusion Criteria:
- • Scoliosis with a possible non-idiopathic ethiology. Patients will be excluded from the study if the pathogenesis of the scoliosis is not idiopathic, but due to a neuromuscular, neurological, congenital malformation or trauma related comorbidity.
- • Previous brace or surgical treatment for scoliosis.
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sundsvall, , Sweden
Stockholm, , Sweden
Jönköping, , Sweden
Västerås, , Sweden
Eskilstuna, , Sweden
Linköping, , Sweden
Umeå, , Sweden
Patients applied
Trial Officials
Paul Gerdhem, MD, PhD
Principal Investigator
Karolinska Institutet, Karolinska University Hospital
Allan Abbott, MPhyt, PhD
Study Director
Linköping University- Sweden, Linköping and Karolinska University Hospital - Sweden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials